ABBV

AbbVie Inc
155.35
-0.77 (-0.49%)
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.77 -0.49% 155.35 12:18:55
Open Price Low Price High Price Close Price Prev Close
156.67 155.28 157.05 156.12
more quote information »

Recent News

Date Time Source Heading
3/21/20237:56IHNWFeaturedPredictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
3/20/202317:01EDGARProxy Statement (definitive) (def 14a)
3/18/202310:03PRNUSAbbVie Announces Late-Breaking Results of Study Evaluating..
3/15/202317:01EDGARStatement of Changes in Beneficial Ownership (4)
3/15/202308:03PRNUSAbbVie Partners with Award-Winning Redglass Pictures on New..
3/13/202308:03PRNUSAbbVie Showcases Strength of Dermatology Portfolio with New..
3/08/202308:45PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Partners with..
3/08/202308:00PRNUSAbbVie to Present at the Barclays Global Healthcare..
3/06/202317:02EDGARProxy Statement - Notice of Shareholders Meeting..
3/02/202317:08EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202317:08EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202317:05EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202317:04EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202317:03EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202316:31EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202316:31EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202308:51PRNUSAbbVie to Present at the Cowen 43rd Annual Health Care..
2/27/202306:00PRNUSAbbVie Highlights Robust Gastroenterology Portfolio with New..
2/27/202302:00PRNUSAbbVie Receives Positive CHMP Opinion for Upadacitinib..
2/23/202305:01PRNUSAbbVie and Capsida Biotherapeutics Expand Strategic..
2/23/202304:59PRNUSAbbVie and Capsida Biotherapeutics Expand Strategic..
2/22/202317:03EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:17EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:13EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:12EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:11EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:10EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:09EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:07EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:06EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:02EDGARStatement of Changes in Beneficial Ownership (4)
2/21/202318:01EDGARStatement of Changes in Beneficial Ownership (4)
2/16/202312:41PRNUSAbbVie Declares Quarterly Dividend
2/16/202306:01EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202310:56EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202310:55DJNAbbVie on Pace for Largest Percent Increase Since October..
2/09/202307:56EDGARCurrent Report Filing (8-k)
2/09/202307:44PRNUSAbbVie Reports Full-Year and Fourth-Quarter 2022 Financial..
1/25/202311:42PRNUSAllergan Aesthetics takes a 360°approach to non-surgical..
1/18/202308:00PRNUSJUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION..
1/17/202308:00PRNUSSkinMedica® Launches Even & Correct
1/16/202309:00GLOBESirona Biochem Announces the Termination of Supply Agreement..
1/10/202308:50DJNAbbVie, Anima Biotech to Collaborate on mRNA Biology..
1/10/202308:16EDGARCurrent Report Filing (8-k)
1/10/202308:00PRNUSAbbVie and Anima Biotech Announce Collaboration for the..
1/09/202307:01PRNCAQULIPTA™ Now Approved by Health Canada for the Preventive..
1/06/202316:16EDGARCurrent Report Filing (8-k)
1/06/202308:00BWAbbVie and Immunome Announce Strategic Collaboration to..
1/05/202308:00PRNUSAbbVie to Host Fourth-Quarter 2022 Earnings Conference Call
1/03/202317:07EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202308:00PRNUSAbbVie to Present at the 41st Annual J.P. Morgan Healthcare..